Greenbrook TMS Company Description

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States.

Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared neurostimulation therapy for the treatment of major depressive disorder and other mental health disorders.

The company also offers Spravato, an esketamine nasal spray; and other treatment modalities for the treatment of depression and related psychiatric services.

Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada. As of December 9, 2024, Greenbrook TMS Inc. operates as a subsidiary of Neuronetics, Inc.

Greenbrook TMS Inc.

Country	Canada
Founded	2011
Industry	Medical Care Facilities
Sector	Healthcare
Employees	489
CEO	William Leonard

Contact Details

Address: 890 Yonge Street Toronto, Ontario M4W 3P4 Canada
Phone	416 322 9700
Website	greenbrooktms.com

Stock Details

Ticker Symbol	GBNHF
Exchange	OTCMKTS
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	8093

Key Executives

Name	Position
William P. Leonard	President, Chief Executive Officer and Director
Peter Willett	Chief Financial Officer
Dr. Geoffrey Garland Grammer M.D.	Chief Medical Officer
Andrew Crish	Chief Operating Officer
Glen Akselrod	Investor Relations Officer
Iris Krug	Vice President of Compliance and Privacy Officer
Brittany Schwemmer	Vice President of Human Resources